The API of GlaxoSmithKline's HIV therapy Tivicay (dolutegravir) will be made in China by Shanghai-based Desano Pharmaceuticals under a deal with the British drug maker's ViiV Healthcare arm, according to a press release.
More than a few analysts and company executives are watching Indian drug companies in expectations of consolidation among smaller players and possibly daring moves by mid-cap and larger at home and abroad.
India's Wockhardt has voluntarily recalled 85,000 cartons of over-the-counter heartburn treatment famotidine tablets, calling the state of its plans to recover from U.S. FDA import bans on two plants into further question, Business Line said.
French contract drugmaker Novasep is investing €10 million ($11 million) to build an antibody-drug conjugate facility at its Le Mans outpost.
India's Central Drugs and Standards Control Organisation (CDSCO) has told staff to forget holidays and weekends as it undertakes a massive drug inspection exercise it intends to complete by the end of the year.
India may soon make scuttlebutt on medical device price controls a reality, starting with orthopedic implants, the Times of India reports, as the National Pharmaceutical Pricing Authority asks Johnson & Johnson, Zimmer and Stryker to submit details of production and pricing of their products, including those for knee and hip.
India's alphabet soup of ministries and agencies that have a role in national pharmaceutical policies will have to get to know each other better under the latest big idea to streamline decision-making and set policies.
Mylan has filled out details on an expanded recall of two drugs manufactured by Bangalore-based Agila Onco, which it bought from Strides Arcolab two years ago, as the company works to fend off a takeover offer from Teva Pharmaceuticals, while moving on its own unsolicited bid for Perrigo.
In something of a surprise move, Japan's NanoCarrier submitted a Phase I application to the Pharmaceuticals and Medical Devices Agency for oncology candidate NC-6004, Nanoplatin, on June 9.
Jubilant Life Sciences has turned a corner at its HollisterStier sterile manufacturing facility in Washington state, highlighting an Indian success story of sorts on the long road of U.S. FDA manufacturing inspections.